Metabolic syndrome and central fat distribution are related to lower serum osteocalcin concentrations

Annals of Nutrition and Metabolism

Volumn 62, Issue 3, 2013, Pages 183-188

  Magalhães, Karina Bezerra Dos Santos ^a   Magalhães, Marcelo Moreira ^a   Diniz, Erik Trovão ^a   Lucena, Cynthia Salgado ^a   Griz, Luiz ^a   Bandeira, Francisco ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

C telopeptide; Metabolic syndrome; Osteocalcin; Waist circumference

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD LEVEL; BODY FAT DISTRIBUTION; BODY MASS; CENTRAL FAT DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; FEMALE; HUMAN; HYPERTENSION; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OSTEOCALCIN BLOOD LEVEL; PREMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BONE TURNOVER; DISEASE ASSOCIATION; DISEASE COURSE; GLUCOSE BLOOD LEVEL; LIPID METABOLISM; OSTEOLYSIS; PROTEIN BLOOD LEVEL;

ADIPOSITY; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; BONE AND BONES; BONE RESORPTION; COLLAGEN TYPE I; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OSTEOCALCIN; OVERWEIGHT; PEPTIDES; PREMENOPAUSE; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84878017524     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000342561     Document Type: Article

References (30)

1. Cornier MA, Dabelea D, Hernandez TL, et al: The metabolic syndrome. Endocr Rev 2008; 29: 777-822.
2. Barros ZM, Salgado C, Bandeira F: Síndrome metabólica; in Bandeira F, Graf H, Griz L, Faria M, Lazaretti-Castro M (eds): Endocrinologia e Diabetes, ed 2. Rio de Janeiro, Med-Book, 2009, pp 984-992.
3. Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005; 28: 2745-2749.
4. Leite MLC, Nicolosi A, Firmo JOA, et al: Features of metabolic syndrome in non-diabetic Italians and Brazilians: a discriminant analysis. Int J Clin Pract 2007; 61: 32-38.
5. Alberti K, Zimmet P, Shaw J: Metabolic syndrome-a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
6. Lee NK, Sowa H, Hinoi E, et al: Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130: 456-469.
7. Ferron M, Hinoi E, Karsenty G, et al: Osteocalcin differentially regulates-cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008; 105: 5266-5270.
8. Kim YS, Paik IY, Rhie YJ, et al: Integrative physiology: defined novel metabolic roles of osteocalcin. J Korean Med Sci 2010; 25: 985-991.
9. Martin TJ: A skeleton key to metabolism. Nat Med 2007; 13: 1021-1023.
10. Pittas AG, Harris SS, Eliades M, et al: Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009; 94: 827-832.
11. Yeap BB, Chubb SAP, Flicker L, et al: Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol 2010; 163: 265-272.
12. Saleem U, Mosley TH Jr, Kullo IJ: Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 2010; 30: 1474-1478.
13. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org.
14. Mancini MC: Obesidade: epidemiologia, diagnóstico e tratamento clinico; in Bandeira F, Graf H, Griz L, Faria M, Lazaretti-Castro M (eds): Endocrinologia e Diabetes, ed 2. Rio de Janeiro, MedBook, 2009, pp 1018-1028.
15. Lee NK, Karsenty G: Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab 2008; 19: 161-166.
16. Hwang YC, Jeong IK, Ahn KJ, et al: The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced-cell function in middle-aged male subjects. Diabetes Metab Res Rev 2009; 25: 768-772.
17. Shea MK, Gundberg CM, Meigs JB, et al: Carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr 2009; 90: 1230-1235.
18. Kanazawa I, Yamaguchi T, Yamamoto M, et al: Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009; 94: 45-49.
19. Fernández-Real JM, Izquierdo M, Ortega F, et al: The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 2009; 94: 237-245.
20. Gundberg CM, Looker AC, Nieman SD, et al: Patterns of osteocalcin and bone-specific alkaline phosphatase by age, gender, and race or ethnicity. Bone 2002; 31: 703-708.
21. Foresta C, Strapazzon G, De Toni L, et al: Evidence for osteocalcin production by adipose tissue and its role in human metabolism. J Clin Endocrinol Metab 2010; 95: 3502-3506.
22. Gerdhem P, Isaksson A, Akesson K, et al: Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 2005; 16: 1506-1512.
23. Akin O, Göl K, Aktürk M, et al: Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol 2003; 17: 19-29.
24. Achemlal L, Tellal S, Rkiouak F, et al: Bone metabolism in male patients with type 2 diabetes. Clin Rheumatol 2005; 24: 493-496.
25. Dobnig H, Piswanger-Sölkner JC, Roth M, et al: Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab 2006; 91: 3355-3363.
26. Kanazawa I, Yamaguchi T, Yamauchi M, et al: Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009; 94: 3031-3037.
27. Okazaki R, Totsuka Y, Hamano K, et al: Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab 1997; 82: 2915-2920.
28. Pérez-Castrillón JL, Justo I, Silva J, et al: Bone mass and bone modelling markers in hypertensive postmenopausal women. J Hum Hypertens 2003; 17: 107-110.
29. Olmos JM, Hernández JL, Martínez J, et al: Bone turnover markers and bone mineral density in hypertensive postmenopausal women on treatment. Maturitas 2010; 65: 396-402.
30. Reid IR, Ames RW, Orr-Walker BJ, et al: Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 2000; 109: 362-370.